about
Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing CancersPhase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate CancerStudy of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or GliosarcomaStudy of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or LymphomaStudy of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies
P859
description
americká firma
@cs
company in Flemington, United States
@en
name
Arno Therapeutics (United States)
@en
Arno Therapeutics
@fr
type
label
Arno Therapeutics (United States)
@en
Arno Therapeutics
@fr
prefLabel
Arno Therapeutics (United States)
@en
Arno Therapeutics
@fr
P159
P2427
grid.476111.4